Looking to publish in Cytotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.
Looking to publish in Cytotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cytotherapy accepts the following article types. Click on an article type to view submission instructions.
Full-Length Articles
Review Articles
Short Reports
Brevia
Letters To The Editors
Recent Publications
Corrigendum to <‘Tunable dissolvable p2 microcarriers enable cell-type dependent scaling of exosome production in L929 and C2C12 cultures’><[Cytotherapy, Volume 28, Issue 5, Supplement, May 2026, 102349]>
P. Radfar, J. Toting, S. Ghobadi, S. Lovell, P. Tushar, M. Ebrahimi Warkiani, S. Oh, L. Ding
CAR T cells: The next frontier
Patrick J. Hanley, Edwin M. Horwitz
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 31 days from submission to decision after review; 91 days from submission to acceptance.
Reformat to Cytotherapy using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3500 excluding taxes for all article types. Subscription publication has no open access publication fee.
Reformat to Cytotherapy using Livewrite Premium